3 episodi

We’ll learn from life science leaders about the groundbreaking work they’re involved with, and the journey they’ve taken to get to where they are in their career today - what motivates them, how they made it to the C suite in the first place, what it takes to stay there, and where they plan to go next. Guests are positioned as expert minds on compelling missions. The chance to align with personalities and brands on a similar journey is a major draw for talent in today’s busy marketplace. An appearance on the podcast serves as a priceless piece of branding collateral that employers can guarantee represents their message faithfully. Moreover, the podcast affords our guests a platform to draw international attention to the work their organisation is doing, introducing their brand to a global audience of potential investors in the process.

High Potential Start-Ups Nick Taylor

    • Economia

We’ll learn from life science leaders about the groundbreaking work they’re involved with, and the journey they’ve taken to get to where they are in their career today - what motivates them, how they made it to the C suite in the first place, what it takes to stay there, and where they plan to go next. Guests are positioned as expert minds on compelling missions. The chance to align with personalities and brands on a similar journey is a major draw for talent in today’s busy marketplace. An appearance on the podcast serves as a priceless piece of branding collateral that employers can guarantee represents their message faithfully. Moreover, the podcast affords our guests a platform to draw international attention to the work their organisation is doing, introducing their brand to a global audience of potential investors in the process.

    Emil Pot, Co-Founder and CEO of Allero Therapeutics

    Emil Pot, Co-Founder and CEO of Allero Therapeutics

    As something that affects as much as 10% of the global population, food allergies are an important topic of discussion in this value-packed episode of High Potential Start-ups.
    In episode 3, guest speaker Emil Pot, Co-Founder and CEO of Allero Therapeutics, and host Nick Ross, Co-Founder of Cavenagh Health, delve into numerous talking points surrounding everything from food-related immune disorders to running a successful biotech company. 
    Emil’s career started in law, but his keen interest in science quickly led to biotech becoming the central point of his career.
    Now, Emil and his team at Allero Therapeutics have developed an innovative solution to treating autoimmune disorders like celiac disease.
    Get in touch with Emil.
    Get in Touch with Nick.

    • 49 min
    João Seixas, CEO of TargTex

    João Seixas, CEO of TargTex

    In episode 2 of the High Potential Start-Ups podcast, we’re joined by CEO of TargTex, João Seixas. 
    João has a great ambition and an incredible passion for the treatment of brain cancer, and it’s woven through the operations of the business. During this insightful conversation, João details his career, from his journey from academia to business, what he picked up from each step of his career, and how that molded him into the leader that he is today. 
    João always felt that the world of academics and research were very comfortable and familiar territories, and he moved into industry because he wanted to challenge himself scientifically. That led him to TargTex, a business with a big vision - to help increase the life expectancy of neuro-oncology patients. 
    In this episode, you’ll find out how to take health from the lab to industry, and get so many more golden nuggets from João.

    • 44 min
    Shardi Nahavandi, CEO & Co-founder at Tuune

    Shardi Nahavandi, CEO & Co-founder at Tuune

    During this inspiring conversation, Shardi reveals the personal story behind starting Tuune, why she hires for mindset over skillset, and why Tuune is fundamentally a learning company.

    • 50 min

Top podcast nella categoria Economia

GURULANDIA
Marco Cappelli & Roberto Vertucci
The Bull - Il tuo podcast di finanza personale
Riccardo Spada
STORIE DI BRAND
MAX CORONA
Market Mover
Il Sole 24 Ore
Marco Montemagno - Il Podcast
Marco Montemagno
4 soldi da investire
MF - Milano Finanza | PodClass